Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeo Yoshikawa is active.

Publication


Featured researches published by Takeo Yoshikawa.


Neuropsychopharmacology | 1997

Reduced Sensitivity to Glucocorticoid Feedback and Reduced Glucocorticoid Receptor mRNA Expression in the Luteal Phase of the Menstrual Cycle

Margaret Altemus; Laura Redwine; Yung-Mei Leong; Takeo Yoshikawa; Rachel Yehuda; Savilla Detera-Wadleigh; Dennis L. Murphy

We examined the effects of the menstrual cycle on hypothalamic-pituitary adrenal axis regulation in healthy women with no history of psychiatric illness by measuring plasma cortisol responses to a low-dose (0.25 mg) of dexamethasone (N = 23) and by measuring glucocorticoid receptor (type II) mRNA expression in lymphocytes using Northern blotting (N = 19). Both measures were performed in the early follicular and mid-luteal phases of the menstrual cycle. Dexamethasone suppression of plasma cortisol was greater in the follicular phase of the menstrual cycle compared to the mid-luteal phase (p <. 01). In addition, type II glucocorticoid receptor mRNA expression in lymphocytes was 78% higher in the follicular phase compared to the mid-luteal phase (p <. 02). These results indicate that glucocorticoid feedback regulation of the hypothalamic-pituitary-adrenal axis is reduced in the mid-luteal phase of the menstrual cycle. Reduced feedback regulation of central stress response systems may play a role in generation of common premenstrual symptoms of irritability and dysphoria.


American Journal of Medical Genetics | 1998

Serotonin transporter (5‐HTT) gene and bipolar affective disorder

Lisa E. Esterling; Takeo Yoshikawa; Gordon Turner; Judy A. Badner; Dietmar Bengel; Elliot S. Gershon; Wade H. Berrettini; Sevilla D. Detera-Wadleigh

Interactions with antidepressants, as well as other biochemical evidence, implicate the serotonin transporter 5-HTT in the etiology of affective disorders. However, genetic studies have produced conflicting results concerning an association of 5-HTT with bipolar disorder. We examined a variable number tandem repeat in the regulatory region of this gene to investigate the possible contribution of 5-HTT to bipolar disorder susceptibility in a 22-pedigree series. By affected-sib-pair analysis and the transmission/disequilibrium test, we found no significant linkage or association of 5-HTT to bipolar disorder. During the course of this study, we adapted a PCR technique designed to amplify long templates to replicating long GC stretches with complex structure. We also refined the location of 5-HTT by radiation hybrid mapping, placing the locus between D17S1294 and SHGC11022 on 17q11.2.


American Journal of Medical Genetics | 1997

Isolation of chromosome 18‐specific brain transcripts as positional candidates for bipolar disorder

Takeo Yoshikawa; Alan R. Sanders; Lisa E. Esterling; Joan Overhauser; Jeffrey Garnes; Greg Lennon; Raji P. Grewal; Sevilla D. Detera-Wadleigh

Several studies have proposed the existence of susceptibility loci for bipolar disorder on chromosome 18. To identify possible candidate genes for this disease, we isolated brain-expressed transcripts by direct cDNA selection on chromosome 18-specific biotinylated cosmid clones. Longer cognate cDNA clones of the selected cDNAs were isolated from a normalized infant brain cDNA library. Physical mapping by PCR on a panel of somatic cell hybrids was conducted by the use of primers derived from partial sequences on either the 5 or 3 ends of the clones. In our initial analysis, 48 cDNA clones were found to be chromosome 18-specific, mapping to different subchromosomal regions. Sequence redundancy among these clones yielded 30 unique transcripts, five of which were represented in previously known genes. Further sequencing of the remaining 25 unique cDNA clones confirmed the absence of significant homology to known genes, indicating that these transcripts represented novel genes. Mapping with the use of a radiation hybrid panel positioned the brain cDNAs to within = 100 to 1100 kb from reference sequence tag sites (STSs) and assembled them into six high resolution linkage groups. The majority of the transcripts were found to cluster to discrete locations on 18p and 18q, previously hypothesized as susceptibility regions for bipolar disorder, identifying them as positional candidate genes.


Biochimica et Biophysica Acta | 1995

DETECTION, SIMULTANEOUS DISPLAY AND DIRECT SEQUENCING OF MULTIPLE NUCLEAR HORMONE RECEPTOR GENES USING BILATERALLY TARGETED RNA FINGERPRINTING

Takeo Yoshikawa; Guo-qiang Xing; Sevilla D. Detera-Wadleigh

We have developed a PCR-based method to detect, display and directly sequence multiple members of the nuclear hormone receptor (NHR) gene family. Our approach employs the basic concepts of RNA fingerprinting (Welsh et al. (1992) Nucleic Acids Res. 20, 4965-4970; Stone, B. and Wharton, W. (1994) Nucleic Acids Res. 22, 2612-2618) and differential display PCR (Liang, P. and Pardee, A.B. (1992) Science 257, 967-971), with modifications. In contrast to the previous methods, two conserved regions within the gene family were targeted to derive primers for PCR amplification. One of the conserved sites was used to deduce primers for cDNA synthesis. We believe that this strategy led to increased specificity. The use of degenerate primers with low redundancy in both reverse transcription and PCR steps also contributed to enhanced signal-to-noise ratio. The ability to directly sequence the amplified fragments constitutes a vast improvement over the previous methods. This method permitted the successful identification and simultaneous display of six different NHR genes, which included the previously unreported rat homolog of COUP-TFI and a recently described orphan receptor. We believe that this approach provides a convenient and rapid screening method for detecting and characterizing members of a gene family.


British Journal of Haematology | 1997

Deletion of a consensus oestrogen response element half-site in the glucocorticoid receptor of human multiple myeloma

Jayaprakash D. Karkera; Susan E. Taymans; Gordon Turner; Takeo Yoshikawa; Sevilla D. Detera-Wadleigh

We have carried out molecular scanning of the glucocorticoid receptor (GR) of the glucocorticoid resistant multiple myeloma cell line U266. An amplified fragment from the 3′ untranslated region displayed an aberrant migration by PCR–single‐stranded conformational polymorphism (PCR‐SSCP) analysis. The mutant allele had a deletion of an 8 base pair sequence containing a half‐site of an oestrogen response element. This motif was found conserved in rat GR. This same allele lacked four As in an upstream region with 18 consecutive As in the normal allele. These mutations may affect mRNA stability or alter interactions with regulatory factors.


Molecular Psychiatry | 1997

An integrated physical map of 18p11.2: a susceptibility region for bipolar disorder

Lisa E. Esterling; T Cox Matise; Alan R. Sanders; Takeo Yoshikawa; Joan Overhauser; Elliot S. Gershon; M T Moskowitz; Sevilla D. Detera-Wadleigh

The reported linkage between bipolar disorder and a large pericentric portion of chromosome 18 has been replicated in an independent study. Further examination of this region showed that 18p11.2 had the greatest allele sharing in our pedigrees and increased sharing in other independently ascertained pedigree series permitting refinement of the region of significance. To facilitate positional cloning of a susceptibility gene, we used a combination of mapping reagents, including a subchromosomal somatic cell hybrid panel, a contig of clones in yeast artificial chromosomes (YAC), and a radiation hybrid (RH) panel, to construct a high resolution physical map of the region including sequence tag sites (STSs) and expressed sequence tags (ESTs). This approach generated the interlocus distance and order of 15 STSs and 16 ESTs including four novel transcripts, with an average of ~200u2009kb between loci, over a ~6-Mb region. This high resolution integrated map will be an important tool in providing loci for contig construction, and positional candidates for mutation screening.


Cancer Genetics and Cytogenetics | 1999

Systematic screening of chromosome 18 for loss of heterozygosity in esophageal squamous cell carcinoma.

Jayaprakash D. Karkera; Kannan V. Balan; Takeo Yoshikawa; Timothy O. Lipman; Louis Korman; Aparna Sharma; Robert H. Patterson; Nirmal Sani; Sevilla D. Detera-Wadleigh

Esophageal cancer ranks among the 10 most common cancers in the world, and is almost uniformly fatal. The genetic events leading to the development of esophageal carcinoma are not well established. To identify genomic regions involved in esophageal carcinogenesis, we performed a systematic screening for loss of heterozygosity (LOH) in 24 samples of squamous cell carcinomas, initially focusing the analysis on chromosome 18. Thirteen short tandem repeat markers spanning 18p and 18q were used. We found a broad peak of LOH spanning 18p11.2 and 18q21.1 with the most frequent LOH (72%) at D18S978 on 18q12.2, which coincides with a known fragile site FRA18A. This region is 4 cM proximal to known tumor suppressor genes and therefore suggests the possible existence of a yet undiscovered tumor suppressor gene.


Proceedings of the National Academy of Sciences of the United States of America | 1999

A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2

Sevilla D. Detera-Wadleigh; Wade H. Berrettini; Takeo Yoshikawa; Lynn R. Goldin; Gordon Turner; Denise Y. Rollins; Tracy Moses; Alan R. Sanders; Jayaprakash D. Karkera; Lisa E. Esterling; Jin Zeng; Thomas N. Ferraro; Juliet J. Guroff; Diane Kazuba; Mary E. Maxwell; John I. Nurnberger; Elliot S. Gershon


Genomics | 1996

Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2

Takeo Yoshikawa; Zoran Brkanac; Barbara R. Dupont; Guo Qiang Xing; Robin J. Leach; Sevilla D. Detera-Wadleigh


Genomics | 1998

Multiple Transcriptional Variants and RNA Editing inC18orf1,a Novel Gene with LDLRA and Transmembrane Domains on 18p11.2 ☆

Takeo Yoshikawa; Alan R. Sanders; Lisa E. Esterling; Sevilla D. Detera-Wadleigh

Collaboration


Dive into the Takeo Yoshikawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lisa E. Esterling

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gordon Turner

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lynn R. Goldin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Denise Y. Rollins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara R. Dupont

University of Texas Health Science Center at San Antonio

View shared research outputs
Researchain Logo
Decentralizing Knowledge